GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Shiller PE Ratio

Alkermes (STU:8AK) Shiller PE Ratio : (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Alkermes Shiller PE Ratio Historical Data

The historical data trend for Alkermes's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Shiller PE Ratio Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkermes Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Alkermes's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkermes's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkermes's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkermes's Shiller PE Ratio falls into.



Alkermes Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alkermes's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Alkermes's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.193/120.9901*120.9901
=0.193

Current CPI (Mar. 2024) = 120.9901.

Alkermes Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.015 100.773 0.018
201409 -0.210 100.474 -0.253
201412 0.162 99.576 0.197
201503 -0.194 99.975 -0.235
201506 -0.276 100.573 -0.332
201509 -0.481 100.274 -0.580
201512 -0.422 99.676 -0.512
201603 -0.458 99.676 -0.556
201606 -0.276 101.072 -0.330
201609 -0.365 100.274 -0.440
201612 -0.133 99.676 -0.161
201703 -0.421 100.374 -0.507
201706 -0.249 100.673 -0.299
201709 -0.201 100.474 -0.242
201712 -0.051 100.075 -0.062
201803 -0.324 100.573 -0.390
201806 -0.180 101.072 -0.215
201809 -0.189 101.371 -0.226
201812 -0.053 100.773 -0.064
201903 -0.549 101.670 -0.653
201906 -0.239 102.168 -0.283
201909 -0.309 102.268 -0.366
201912 -0.027 102.068 -0.032
202003 -0.217 102.367 -0.256
202006 -0.169 101.769 -0.201
202009 -0.001 101.072 -0.001
202012 -0.222 101.072 -0.266
202103 -0.118 102.367 -0.139
202106 0.008 103.364 0.009
202109 -0.153 104.859 -0.177
202112 0.009 106.653 0.010
202203 -0.200 109.245 -0.222
202206 -0.170 112.779 -0.182
202209 -0.394 113.504 -0.420
202212 -0.160 115.436 -0.168
202303 -0.233 117.609 -0.240
202306 1.274 119.662 1.288
202309 0.262 120.749 0.263
202312 0.605 120.749 0.606
202403 0.193 120.990 0.193

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alkermes  (STU:8AK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Alkermes Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Alkermes's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkermes (STU:8AK) Business Description

Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines